Please login to the form below

Not currently logged in
Email:
Password:

ArchiMed acquires life sciences consultancy Deallus

Healthcare private equity firm is also looking at a number of 'bolt-on' deals

Deallus Claudio D'AmbrosioArchiMed, Europe's first independent private equity healthcare specialist, has acquired majority control of Deallus Consulting.

The financial details have not been published. The acquisition was the result of a proprietary process, with senior managers at Deallus reinvesting all proceeds from the deal into the group. 

ArchiMed is also reviewing a number of possible bolt-on acquisitions for Deallus, the former said in a statement. 

Deallus chief executive Claudio D'Ambrosio (pictured) said: “We are excited to work in partnership with ArchiMed and leverage their networks in both the consulting and healthcare industries to take Deallus into the next phase of its growth.”

He told PMLiVE: “While the operations of Deallus will remain largely intact, with the same people and processes, the partnership with ArchiMed expands the depth and breadth of our expertise. We now have an unparalleled global perspective that will be extremely useful in growing our services developing innovative approaches for clients to address markets needs around the world.

D'Ambrosio added that acquiring Deallus would enable ArchiMed to be more involved in pharma services.

He explained that the acquisition will have no implication for staff numbers at Deallus for the foreseeable future, although reviews will take place periodically. 

Asked whether the Deallus brand would change, D'Ambrosio told PMLiVE: “No. We'll remain Deallus. Our brand is very well known in North America, as is ArchiMed in Europe.”

“What we do see, though, is the market recognising that the two entities are now part of the same team.”

Global life sciences consultancy Deallus has a staff of 80 consultants with headquarters in London and offices in New York, Los Angeles, Princeton, Tokyo and Singapore.

Since its founding in 2004, Deallus's annual revenue growth has averaged at some 20% and turnover in the company's most recent fiscal year stood at £15m.

Robin Filmer-Wilson, a managing partner of ArchiMed, said:“Deallus does exactly what a specialist consultant should do, it inspires clients to develop best-in-class strategies through exceptionally deep market understanding and insight.

“We intend to accelerate the growth of Deallus by providing access to new accounts, aiding recruitment and helping to set up additional offices globally.”

Article by
Tara Craig

14th December 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics